Get the Stockscreener App
4.16
1.89%
-0.08
After Hours:
4.18
0.02
+0.48%
Eagle Pharmaceuticals Inc Stock (EGRX) Forecast
The Eagle Pharmaceuticals Inc (EGRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $17.14, representing a +312.02% increase from the current price of $4.16. The highest analyst price target is $21.82, and the lowest is $12.46.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EGRX Price Target
Average 24.22
(+482.18% Upside)
Is Eagle Pharmaceuticals Inc (EGRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.69 | Neutral |
| STOCH(9,6) | 25.50 | Neutral |
| STOCHRSI(14) | 6.1345 | Buy |
| MACD(12,26) | -0.2713 | Sell |
| ADX(14) | 15.78 | Neutral |
| William %R | -90.91 | Buy |
| CCI(14) | -204.48 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.564
Sell
|
4.5175
Sell
|
| MA20 |
4.707
Sell
|
4.7264
Sell
|
| MA50 |
5.4108
Sell
|
5.1983
Sell
|
| MA100 |
5.302
Sell
|
6.4921
Sell
|
| MA200 |
10.25
Sell
|
10.56
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EGRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on EGRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.69 indicates that EGRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 25.5 indicates that EGRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.1345 indicates that EGRX is oversold. This suggests that EGRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.78 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -204.48 indicates that EGRX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term EGRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eagle Pharmaceuticals Inc financial reports and earnings history, Eagle Pharmaceuticals Inc (EGRX) stock could reach $12.41 by 2030, $1.7086 by 2040 and $33.51 by 2050. See the projected annual prices until 2050 of the Eagle Pharmaceuticals Inc stock below:
- Eagle Pharmaceuticals Inc (EGRX) is expected to reach an average price of $2.5735 in 2035, with a high prediction of $4.1391 and a low estimate of $0.9838. This indicates an $-38.14% rise from the last recorded price of $4.16.
- Eagle Pharmaceuticals Inc (EGRX) stock is projected to chart a bullish course in 2040, with an average price target of $0.1906, representing an $-95.42% surge from its current level. The forecast ranges from a conservative $0.0749 to a sky-high $1.7086.
- Our analysts predict Eagle Pharmaceuticals Inc (EGRX) to jump 301.09% by 2045, soaring from $11.50 to an average price of $16.69, potentially reaching $13.56. While $11.50 is the low estimate, the potential upside is significant.
- Eagle Pharmaceuticals Inc (EGRX) stock is expected to climb by 2050, reaching an average of $34.44, a $727.91% jump from its current level. However, a wide range of estimates exists, with high and low targets of $33.51 and $34.82, respectively, highlighting the market's uncertainty.
Eagle Pharmaceuticals Inc Stock (EGRX) Year by Year Forecast
Eagle Pharmaceuticals Inc Stock (EGRX) Price Forecast for 2024
Our forecast for EGRX stock price in 2024 now indicates an average price target of $20.21 with a high forecast of $35.98 and a low forecast of $4.4324. The average prediction reflects an increase of +385.75% from the last recorded price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $18.66 | $12.46 | $21.82 | +348.46% |
| June, 2024 | $19.29 | $18.29 | $27.19 | +363.72% |
| July, 2024 | $25.46 | $17.89 | $26.98 | +511.94% |
| August, 2024 | $24.72 | $21.77 | $26.67 | +494.27% |
| September, 2024 | $26.12 | $19.52 | $29.63 | +527.94% |
| October, 2024 | $26.83 | $23.73 | $30.10 | +545.00% |
| November, 2024 | $32.55 | $25.82 | $33.62 | +682.38% |
| December, 2024 | $28.22 | $26.04 | $35.98 | +578.43% |
Eagle Pharmaceuticals Inc Stock (EGRX) Price Forecast for 2025
Eagle Pharmaceuticals Inc Stock (EGRX) is expected to reach an average price of $20.44 in 2025, with a high prediction of $34.06 and a low estimate of $6.8142. This indicates an +391.26% rise from the last recorded price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $31.88 | $24.94 | $32.86 | +666.29% |
| February, 2025 | $31.58 | $30.84 | $34.06 | +659.19% |
| March, 2025 | $30.70 | $25.56 | $32.63 | +637.94% |
| April, 2025 | $13.57 | $12.49 | $30.46 | +226.27% |
| May, 2025 | $19.06 | $6.8142 | $19.33 | +358.12% |
| June, 2025 | $24.75 | $15.81 | $29.90 | +495.04% |
| July, 2025 | $27.12 | $23.75 | $30.24 | +551.89% |
| August, 2025 | $20.26 | $16.80 | $28.85 | +387.10% |
| September, 2025 | $26.36 | $19.64 | $26.92 | +533.63% |
| October, 2025 | $18.40 | $13.99 | $26.90 | +342.40% |
| November, 2025 | $13.15 | $12.38 | $19.35 | +216.07% |
| December, 2025 | $18.12 | $12.60 | $20.15 | +335.69% |
Eagle Pharmaceuticals Inc Stock (EGRX) Price Forecast for 2026
The predicted value for Eagle Pharmaceuticals Inc (EGRX) in 2026 is set at an average of $26.85. Estimates vary from a peak of $37.06 to a trough of $16.63, indicating an +545.35% surge from the present price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $23.33 | $18.53 | $25.09 | +460.80% |
| February, 2026 | $24.52 | $22.39 | $30.34 | +489.52% |
| March, 2026 | $23.91 | $21.84 | $26.12 | +474.76% |
| April, 2026 | $25.82 | $23.27 | $30.18 | +520.79% |
| May, 2026 | $24.00 | $22.98 | $29.78 | +476.91% |
| June, 2026 | $20.79 | $18.63 | $25.52 | +399.65% |
| July, 2026 | $23.71 | $18.44 | $24.40 | +469.95% |
| August, 2026 | $21.61 | $17.90 | $25.24 | +419.38% |
| September, 2026 | $23.24 | $16.63 | $24.06 | +458.67% |
| October, 2026 | $27.47 | $21.21 | $27.66 | +560.23% |
| November, 2026 | $30.03 | $26.66 | $30.60 | +621.91% |
| December, 2026 | $33.13 | $28.49 | $37.06 | +696.30% |
Eagle Pharmaceuticals Inc Stock (EGRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eagle Pharmaceuticals Inc (EGRX) is $33.88, with a high forecast of $40.52 and a low forecast of $27.23. This indicates an +714.40% increase from the last price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $37.80 | $30.41 | $38.63 | +808.68% |
| February, 2027 | $34.73 | $34.07 | $40.52 | +734.75% |
| March, 2027 | $31.08 | $30.75 | $37.10 | +647.15% |
| April, 2027 | $37.73 | $28.33 | $38.82 | +806.88% |
| May, 2027 | $30.65 | $28.59 | $39.92 | +636.83% |
| June, 2027 | $32.84 | $27.72 | $33.48 | +689.35% |
| July, 2027 | $29.80 | $28.99 | $33.96 | +616.39% |
| August, 2027 | $36.50 | $27.90 | $38.58 | +777.35% |
| September, 2027 | $29.74 | $27.69 | $37.01 | +614.96% |
| October, 2027 | $34.57 | $27.23 | $35.02 | +730.94% |
| November, 2027 | $28.90 | $27.43 | $34.92 | +594.79% |
| December, 2027 | $31.76 | $28.94 | $34.54 | +663.41% |
Eagle Pharmaceuticals Inc Stock (EGRX) Price Forecast for 2028
In 2028, Eagle Pharmaceuticals Inc (EGRX) is projected to reach an average price of $21.88, with a high projection of $33.08 and a low estimate of $10.67. This indicates an +425.88% rise from the last price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $25.24 | $21.05 | $33.08 | +506.82% |
| February, 2028 | $19.15 | $18.04 | $25.62 | +360.30% |
| March, 2028 | $14.29 | $12.59 | $20.16 | +243.59% |
| April, 2028 | $20.12 | $13.66 | $21.62 | +383.61% |
| May, 2028 | $25.47 | $19.55 | $29.70 | +512.35% |
| June, 2028 | $18.67 | $18.38 | $25.68 | +348.77% |
| July, 2028 | $23.81 | $17.63 | $24.28 | +472.47% |
| August, 2028 | $21.27 | $20.47 | $24.73 | +411.28% |
| September, 2028 | $15.93 | $15.55 | $21.02 | +283.03% |
| October, 2028 | $21.09 | $14.85 | $23.72 | +406.97% |
| November, 2028 | $12.37 | $10.67 | $22.18 | +197.47% |
| December, 2028 | $13.72 | $11.19 | $13.77 | +229.80% |
Eagle Pharmaceuticals Inc Stock (EGRX) Price Forecast for 2029
The 2029 price forecast for Eagle Pharmaceuticals Inc Stock (EGRX) is $14.13 on average, with a high prediction of $28.22 and a low estimate of $0.0474. This represents an +239.75% increase from the previous price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $12.00 | $10.07 | $13.62 | +188.35% |
| February, 2029 | $13.86 | $9.8866 | $14.28 | +233.18% |
| March, 2029 | $10.45 | $10.09 | $16.82 | +151.32% |
| April, 2029 | $9.7108 | $9.0508 | $11.91 | +133.43% |
| May, 2029 | $7.8156 | $6.6694 | $10.03 | +87.87% |
| June, 2029 | $4.0903 | $3.8403 | $9.4991 | -1.67% |
| July, 2029 | $1.1763 | $0.6543 | $4.8115 | -71.72% |
| August, 2029 | $27.95 | $0.0474 | $28.22 | +571.82% |
| September, 2029 | $24.58 | $27.06 | $26.71 | +490.82% |
| October, 2029 | $20.19 | $24.91 | $24.48 | +385.25% |
| November, 2029 | $18.33 | $15.91 | $16.87 | +340.55% |
| December, 2029 | $16.64 | $16.67 | $15.46 | +300.00% |
Eagle Pharmaceuticals Inc Stock (EGRX) Price Forecast for 2030
Eagle Pharmaceuticals Inc Stock (EGRX) is expected to reach an average price of $7.0851 in 2030, with a high forecast of $13.94 and a low forecast of $0.2285. This signifies an +70.31% surge from the last price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.5705 | $13.58 | $12.41 | +57.94% |
| February, 2030 | $10.65 | $10.23 | $8.7883 | +155.91% |
| March, 2030 | $5.6265 | $6.9615 | $10.12 | +35.25% |
| April, 2030 | $7.3946 | $6.797 | $6.6617 | +77.76% |
| May, 2030 | $4.0501 | $4.2675 | $2.9551 | -2.64% |
| June, 2030 | $2.9356 | $3.688 | $3.5428 | -29.43% |
| July, 2030 | $5.2762 | $0.2285 | $5.6462 | +26.83% |
| August, 2030 | $0.6343 | $2.1533 | $7.0233 | -84.75% |
| September, 2030 | $3.4576 | $0.4648 | $5.7076 | -16.89% |
| October, 2030 | $2.487 | $0.417 | $5.0399 | -40.22% |
| November, 2030 | $3.1565 | $0.9618 | $4.7894 | -24.12% |
| December, 2030 | $16.68 | $2.2811 | $13.94 | +301.00% |
1.69%
1.28%
Cap:
|
Volume (24h):